Therefore, lnc-MyD88 and AFP can also be used as effective tumor markers to distinguish HCC from LC, and the AUC value of lnc-MyD88 suggested that lnc-MyD88 had better diagnostic efficiency than AFP in the process of distinguishing HCC from LC. The gene discussed is MYD88; the disease is laryngotracheoesophageal cleft.